[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339217-105":59,"doc-detail-339217-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","upregulation-of-cyr61-by-tgf-and-yap-signaling-exerts-a-counter-suppression-of-hepatocellular-carcinoma-research-article","Upregulation of CYR61 by TGF-β and YAP signaling exerts a counter-suppression of hepatocellular carcinoma - Research article","","Transforming growth factor-β (TGF-β) and Hippo signaling regulate oncogenic and tumor-suppressive programs, yet their coordinated control in hepatocellular carcinoma (HCC) remained unclear. Integrated analyses identified CYR61 as a key candidate reduced in clinical HCC tissues and cell lines. CYR61 is a direct TGF-β target, activated by a Smad2/3–YAP/TEAD4 protein complex on the CYR61 promoter. CYR61 depletion promotes TGF-β/YAP-driven growth and migration, whereas ectopic CYR61 blocks malignant transformation and suppresses xenograft growth in nude mice. Transcriptomics further supports an antitumor program.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/upregulation-of-cyr61-by-tgf-and-yap-signaling-exerts-a-counter-suppression-of-hepatocellular-carcinoma-research-article/339217/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/upregulation-of-cyr61-by-tgf-and-yap-signaling-exerts-a-counter-suppression-of-hepatocellular-carcinoma-research-article/339217.png","ImageObject",300,407,{"name":92,"@type":93},"Ava Thompson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Which gene was identified as a key candidate in liver cancer development?","Question",{"text":113,"@type":114},"CYR61 was identified as a pivotal candidate gene related to HCC development through integrated analysis of public liver cancer databases and experimental TGF-β target genes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does TGF-β regulate CYR61 transcription in liver cancer cells?",{"text":118,"@type":114},"TGF-β-stimulated Smad2/3 and Hippo downstream effectors YAP and TEAD4 form a protein complex on the CYR61 promoter, activating promoter activity and stimulating CYR61 gene transcription.",{"name":120,"@type":111,"acceptedAnswer":121},"What is the functional impact of CYR61 on hepatocellular carcinoma?",{"text":122,"@type":114},"CYR61 depletion enhances TGF-β- or YAP-mediated growth and migration, while ectopic CYR61 impedes TGF-β- or YAP-induced malignant transformation in vitro and attenuates xenograft growth in nude mice.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},339217,1790125893,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","RESEARCH ARTICLE  \nUpregulation of CYR61 by TGF-β and YAP signaling exerts a counter-suppression of hepatocellular carcinoma  \nReceived for publication, September 22, 2023, and in revised form, March 10, 2024 Published, Papers in Press, March 21, 2024, [https://doi.org/10.1016/j.jbc.2024.107208](https://doi.org/10.1016/j.jbc.2024.107208)  \nCheng Zhang 1,2,‡, Wenjing Wei 1,‡, Shuo Tu 1, Bo Liang3, Chun Li2, Yining Li 1, Weicheng Luo 1, Yiqing Wu 1, Xiaohui Dai 1, Yi Wang 1, Lijuan Zheng 1, Liang Hao3, Chunbo Zhang4, Zhijun Luo5, Ye-Guang Chen 1,6, and Xiaohua Yan 1,2, *  \nFrom the 1The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medicine, 2The First Afﬁliated Hospital, 3The Second Afﬁliated Hospital, 4School of Pharmacy, and 5Queen Mary School, Jiangxi Medical College, Nanchang University, Nanchang, China; 6School of Life Sciences, Tsinghua University, Beijing, China  \nReviewed by members of the JBC Editorial Board. Edited by Eric Fearon  \nTransforming growth factor-β (TGF-β) and Hippo signaling are two critical pathways engaged in cancer progression by regulating both oncogenes and tumor suppressors, yet how the two pathways coordinately exert their functions in the development of hepatocellular carcinoma (HCC) remains elusive. In this study, we ﬁrstly conducted an integrated analysis of public liver cancer databases and our experimental TGF-β target genes, identifying CYR61 as a pivotal candidate gene relating to HCC development. The expression of CYR61 is downregulated in clinical HCC tissues and cell lines than that in the normal counterparts. Evidence revealed that CYR61 is a direct target gene of TGF-β in liver cancer cells. In addition, TGF-β-stimulated Smad2/3 and the Hippo pathway downstream effectors YAP and TEAD4 can form a protein complex on the promoter of CYR61, thereby activating the promoter activity and stimulating CYR61 gene transcription in a collaborative manner. Functionally, depletion of CYR61 enhanced TGF-β -or YAP-mediated growth and migration of liver cancer cells. Consistently, ectopic expression of CYR61 was capable of impeding TGF-β -or YAP-induced malignant transformation of HCC cells in vitro and attenuating HCC xenograft growth in nude mice. Finally, transcriptomic analysis indicates that CYR61 can elicit an antitumor program in liver cancer cells. Together, these results add new evidence for the crosstalk between TGF-β and Hippo signaling and unveil an important tumor suppressor function of CYR61 in liver cancer.  \nAs the major form of primary liver cancers, hepatocellular carcinoma (HCC) is one of the most lethal cancer types worldwide (1). The homeostasis of the adult liver is regulated by both transforming growth factor-β (TGF-β) and Hippo signaling pathways, aberration of which contributes to the development of various liver diseases, including liver cancer (2–6). TGF-β is highly expressed in advanced liver cancers and promotes the proliferation, migration, and invasion of cancer cells, among other tumor-promoting actions (6–8). Upon TGF-β stimulation, R-Smad proteins (Smad2/3) and the  \n‡ These authors contributed equally to this work.  \n* For correspondence: Xiaohua Yan, [yanxiaohua@ncu.edu.cn](yanxiaohua@ncu.edu.cn).  \ncommon Smad (Co-Smad, Smad4) form a protein complex and accumulate in the nucleus, where they regulate gene transcription by binding to DNA directly and associating with other transcriptional regulators (9–11).  \nThe Hippo pathway exerts an inhibitory role in liver cancer development by inactivating the downstream transcriptional coactivators YAP and TAZ, which have been frequently found to be hyperactivated or overexpressed in liver cancer (3, 12). Atthe core of the Hippo pathway are MST1/2 and LATS1/2 serine/threonine kinases (13, 14). Once activated by MST1/2, LATS1/2 phosphorylates and inactivates YAP and TAZ. The Hippo kinase cascade is shut off in response to growth factors, cell polarity changes or mechanic c","cbCaifNAbsBPMYD2","https://ap.wps.com/l/cbCaifNAbsBPMYD2","pdf",5282944,15,"English","# Background\n## TGF-β and Hippo pathways in HCC\n## Mechanistic overview: Smads and YAP/TAZ/TEADs\n# Results\n## Integrated analysis identifies CYR61\n## CYR61 is a direct TGF-β target\n## Smad2/3 and YAP/TEAD4 activate the CYR61 promoter\n## Functional effects of CYR61 depletion and overexpression\n## Transcriptomic evidence for an antitumor program\n# Conclusions","[{\"question\":\"Which gene was identified as a key candidate in liver cancer development?\",\"answer\":\"CYR61 was identified as a pivotal candidate gene related to HCC development through integrated analysis of public liver cancer databases and experimental TGF-β target genes.\"},{\"question\":\"How does TGF-β regulate CYR61 transcription in liver cancer cells?\",\"answer\":\"TGF-β-stimulated Smad2/3 and Hippo downstream effectors YAP and TEAD4 form a protein complex on the CYR61 promoter, activating promoter activity and stimulating CYR61 gene transcription.\"},{\"question\":\"What is the functional impact of CYR61 on hepatocellular carcinoma?\",\"answer\":\"CYR61 depletion enhances TGF-β- or YAP-mediated growth and migration, while ectopic CYR61 impedes TGF-β- or YAP-induced malignant transformation in vitro and attenuates xenograft growth in nude mice.\"}]","Upregulation of CYR61 by TGF-β and YAP signaling exerts a counter-suppression of hepatocellular carcinoma - Research article | PDF",1790028781,38,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bbf40fe128b8effe2a87cff56f892f68.webp",983,1296,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e04f380f19525e6fab202355124ac5ba.webp",982,1294,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/958cee6a726ea51a79a25d3c86aeb6ae.webp",981,1293,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b7a8c691f6ee2c1a1a2230d6f365f27c.webp",980,1292]